| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $2.23 (Beat by $0.07) |
| EPS GAAP Actual | $2.23 (Beat by $0.07) |
| Revenue Actual | $6.838B |
| Revenue Surprise | Beat by $6838M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 11.815 | 18.33 | 11.67082 | 12.02607 | 1 |
| Dec 2029 | 11.54 | 18.77 | 11.26534 | 12.03539 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.69 | 1.69 | 6.838B | 4.39% | 6838M |
| FQ3 2025 (Sep 2025) | 1.28 | 1.28 | 6.053B | 43.81% | 6053M |
| FQ2 2025 (Jun 2025) | 0.77 | 0.77 | 5.936B | 3.25% | 5936M |
| FQ1 2025 (Mar 2025) | 1.33 | 1.33 | 5.741B | 39.26% | 5741M |
| FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 6.538B | 42.2% | 6538M |
| FQ3 2024 (Sep 2024) | 1.13 | 1.13 | 3.401B | -102.09% | 3401M |
| FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 5.743B | 29.64% | 5743M |
| FQ1 2024 (Mar 2024) | 1.47 | 1.47 | 3.487B | -105.53% | 3487M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 2.42564 | -- | 2.38637 | 2.46968 | 7 |
| FQ2 2028 (Jun 2028) | 2.14079 | -- | 2.10614 | 2.17966 | 7 |
| FQ1 2028 (Mar 2028) | 2.26503 | -- | 2.22836 | 2.30615 | 7 |
| FQ4 2027 (Dec 2027) | 2.74407 | -- | 2.69856 | 2.80887 | 5 |
| FQ3 2027 (Sep 2027) | 2.15094 | -- | 2.11527 | 2.20174 | 5 |
| FQ2 2027 (Jun 2027) | 2.11862 | -- | 2.08348 | 2.16865 | 5 |
| FQ1 2027 (Mar 2027) | 1.93366 | -- | 1.91153 | 1.95352 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 7.03B | -- | 6.94B | 7.13B | 11 |
| FQ2 2028 (Jun 2028) | 6.93B | -- | 6.84B | 7.02B | 6 |
| FQ1 2028 (Mar 2028) | 6.68B | -- | 6.6B | 6.78B | 6 |
| FQ4 2027 (Dec 2027) | 7.55B | -- | 7.45B | 7.69B | 4 |
| FQ3 2027 (Sep 2027) | 6.61B | -- | 6.52B | 6.73B | 4 |
| FQ2 2027 (Jun 2027) | 6.54B | -- | 6.46B | 6.66B | 7 |
| FQ1 2027 (Mar 2027) | 6.49B | -- | 6.43B | 6.54B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.69 | 1.69 | 100% | |
| FQ3 2025 (Sep 2025) | 1.28 | 1.28 | 100% | |
| FQ2 2025 (Jun 2025) | 0.77 | 0.77 | 100% | |
| FQ1 2025 (Mar 2025) | 1.33 | 1.33 | 100% | |
| FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 100% | |
| FQ3 2024 (Sep 2024) | 1.13 | 1.13 | 100% | |
| FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 100% | |
| FQ1 2024 (Mar 2024) | 1.47 | 1.47 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $6.84B | $6838M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $6.05B | $6053M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $5.94B | $5936M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $5.74B | $5741M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $6.54B | $6538M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.4B | $3401M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.74B | $5743M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.49B | $3487M | 100% |